This discrepancy could be due to the unique pathophysiological mechanisms of anti-CASPR2 encephalitis, potentially related to specific inflammatory pathways or other clinical factors such as complications or treatment protocols. The gene discussed is CNTNAP2; the disease is encephalitis.